Corix Bioscience (Corix Bioscience) Total Stockholders Equity : $3.56 Mil (As of Sep. 2017)

View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience Total Stockholders Equity?

Corix Bioscience's Total Stockholders Equity for the quarter that ended in Sep. 2017 was $3.56 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Corix Bioscience's Book Value per Share for the quarter that ended in Sep. 2017 was $0.17. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Corix Bioscience's Debt-to-Equity for the quarter that ended in Sep. 2017 was 0.01.

Corix Bioscience Total Stockholders Equity Historical Data

The historical data trend for Corix Bioscience's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience Total Stockholders Equity Chart

Corix Bioscience Annual Data

Trend

Jan09

Jan10

Jan11

Jan12

Jan13

Jan14

Jan15

Dec16

Total Stockholders Equity

Get a 7-Day Free Trial

-0.01

-0.02

4.48

Corix Bioscience Quarterly Data
	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Total Stockholders Equity	Get a 7-Day Free Trial															4.38	4.48	-	6.50	3.56

Corix Bioscience (GREY:CXBS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Corix Bioscience's Book Value per Share for the quarter that ended in Sep. 2017 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(3.558	-	0)	/	20.6531
	=	0.17

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Corix Bioscience's Debt-to-Equity for the quarter that ended in Sep. 2017 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.05	+	0)	/	3.558
	=	0.01

Corix Bioscience Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Corix Bioscience (Corix Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085

Website

http://www.corixbioscience.com

Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines